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Abstract 
Background: There has been no evidence of transmission of mosquito-borne arboviruses of equine or human health 
concern to date in the UK. However, in recent years there have been a number of outbreaks of viral diseases spread by 
vectors in Europe. These events, in conjunction with increasing rates of globalisation and climate change, have led to 
concern over the future risk of mosquito-borne viral disease outbreaks in northern Europe and have highlighted the 
importance of being prepared for potential disease outbreaks. Here we assess several UK mosquito species for their 
potential to transmit arboviruses important for both equine and human health, as measured by the presence of viral 
RNA in saliva at different time points after taking an infective blood meal.
Results: The following wild-caught British mosquitoes were evaluated for their potential as vectors of zoonotic 
equine arboviruses: Ochlerotatus detritus for Venezuelan equine encephalitis virus (VEEV) and Ross River virus (RRV), 
and Culiseta annulata and Culex pipiens for Japanese encephalitis virus (JEV). Production of RNA in saliva was demon-
strated at varying efficiencies for all mosquito-virus pairs. Ochlerotatus detritus was more permissive for production 
of RRV RNA in saliva than VEEV RNA. For RRV, 27.3% of mosquitoes expectorated viral RNA at 7 days post-infection 
when incubated at 21 °C and 50% at 24 °C. Strikingly, 72% of Cx. pipiens produced JEV RNA in saliva after 21 days at 18 
°C. For some mosquito-virus pairs, infection and salivary RNA titres reduced over time, suggesting unstable infection 
dynamics.
Conclusions: This study adds to the number of Palaearctic mosquito species that demonstrate expectoration of viral 
RNA, for arboviruses of importance to human and equine health. This work adds to evidence that native mosquito 
species should be investigated further for their potential to vector zoonotic mosquito-borne arboviral disease of 
equines in northern Europe. The evidence that Cx. pipiens is potentially an efficient laboratory vector of JEV at tem-
peratures as low as 18 °C warrants further investigation, as this mosquito is abundant in cooler regions of Europe and 
is considered an important vector for West Nile Virus, which has a comparable transmission ecology.
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Background
Globalisation and climate change are expected to change 
the level of risk for emergence of vector-borne diseases 
in previously unaffected regions. In the last fifty years, 
the geographical range of a number of mosquito-borne 
arboviral diseases has increased, including Zika, dengue, 
chikungunya and West Nile. Mosquito-borne arboviral 
infections which affect both horses and people include, 
amongst others, the flaviviruses West Nile virus (WNV), 
Japanese encephalitis virus (JEV) and Murray Valley 
encephalitis virus (MVEV), and the alphaviruses Ven-
ezuelan equine encephalitis virus (VEEV), Eastern equine 
encephalitis virus (EEEV), Western equine encephalitis 
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virus, and Ross River virus (RRV) [1]. Whilst the emer-
gence in Europe of dengue and chikungunya has been 
associated with Aedes aegypti and the invasive mosquito 
Aedes albopictus [2], for most of the equine viruses Culex 
mosquitoes are significantly involved in transmission. 
Expansion of the range of some arboviruses (West Nile 
virus (WNV) for example) has demonstrated vector com-
petence of previously naïve mosquito species or popula-
tions [3–6]. Other emerging diseases that affect equines 
include Peruvian horse sickness virus [7] and Bunyam-
wera virus [8, 9]. Both are mosquito-borne viruses that 
have emerged as fatal equine diseases, in Peru and Argen-
tina respectively, within the last 25 years. Sindbis and 
Middelburg viruses, circulating in Europe and/or Africa 
have also been recently associated with neurological dis-
ease in horses [10].
There has been much discussion of the risk of equine 
arbovirus introduction to Europe in the last decade [11–
14]. The equine arboviruses generally have complex enzo-
otic transmission cycles involving wildlife as reservoir 
hosts and ‘bridge vectors’ with broad feeding preferences 
which can carry virus from the reservoir host to other 
hosts; including humans and horses, both of which are 
clinically affected. The three viruses investigated in the 
present study (VEEV, RRV, JEV) have significant impacts 
on the health of people and horses (summarised in [15]) in 
endemic areas. Venezuelan equine encephalitis virus cir-
culates in enzootic cycles between rodent hosts and mos-
quito vectors in Mexico, Central and South America [16] 
and has a complex transmission cycle involving regular 
mutation of the virus, facilitating transmission to humans 
and horses through broadening of the vector and host 
ranges. This results in an epizootic cycle during which, 
virus amplification in the horse is sufficient to result in 
mosquito infection and this is thought to significantly 
increase the risk of human infection [17]. VEEV infection 
causes neurological signs in humans and horses and sig-
nificant infection and mortality rates in horses [15, 18].
Ross River virus is active seasonally in Australia with 
a number of vectors implicated. Epidemic polyarthritis 
due to RRV infection is regularly encountered in people 
in Australia  [19], and related signs are seen in infected 
horses including synovial effusion, muscle stiffness and 
exercise intolerance [20]. In Australia, RRV is maintained 
in a transmission cycle between mosquito vectors and 
marsupial hosts. However, a large outbreak occurred in 
the South Pacific in 1979–1980 [21], and other outbreaks 
consistent with human-mosquito-human transmission 
[22] provide evidence that regions without native marsu-
pial hosts may be at risk of limited epizootic outbreaks. 
The predominance of marsupials as reservoirs of RRV 
has been called into question and horses are suggested 
as potentially significant reservoirs by some authors [23]. 
These factors raise the possibility that the potential for 
RRV to spread globally may be greater than previously 
thought.
Japanese encephalitis virus outbreaks have occurred 
from Asia to Oceania [1] and the virus infects a broad 
range of species although the primary transmission cycle 
involves ardeid birds [24]. JEV infection causes neuro-
logical disease and mortality in equines and humans. JEV 
has several secondary vectors as well as the main vector 
Cx. tritaeniorhynchus, and has been identified in numer-
ous species of wild-caught mosquitoes including Cx. pipi-
ens, in which JEV RNA was discovered in Italy in 2011 
[25–27]. Culex pipiens has also been shown to be a labo-
ratory competent vector, as has the invasive mosquito Ae. 
albopictus [28] which is widespread in southern Europe 
[29].
None of these three viruses have been identified in 
the UK; however, to estimate the risk of autochthonous 
transmission (post-introduction) of these viruses in an 
unaffected country it is necessary to consider potential 
native vectors. Several studies have investigated vector 
competence of European mosquitoes for WNV [30, 31], 
including UK populations [32], and for JEV [28, 33, 34]. 
While some mosquito species present both in Europe 
and the Americas or Oceania have had their vector com-
petence assessed for equine alphaviruses such as VEEV 
and RRV [35, 36], to our knowledge no field-collected 
European mosquito populations have been experimen-
tally evaluated for alphaviruses affecting equines.
The aim of this study was to investigate British wild-
caught mosquito species for laboratory transmission 
potential (detection of viral RNA in saliva) of selected 
equine arboviruses, at temperatures which occur in 
the UK now, or may in the future. Viruses (an epidemic 
strain of VEEV, RRV and JEV) were selected based on 
their effects on equine health [15]. Mosquito species 
were selected based on the potential exposure of British 
equines to the candidate vector. During a previous study, 
UK equine premises were sampled for candidate mos-
quito vectors and Cx. pipiens, Culiseta annulata and Oc. 
detritus were collected on a significant number of sites 
[15].
The mosquito-virus combinations tested were JEV in 
Cs. annulata and Cx. pipiens, and RRV and VEEV in Oc. 
detritus. Ochlerotatus detritus has previously been shown 
to be a potential laboratory vector of JEV [34] and so was 
not further tested. None of these mosquito-virus combi-
nations have been tested before, except for JEV and Cx. 
pipiens, which was examined here at a significantly lower 
temperature than previously [28].
The presence of viral RNA in saliva is a pre-requisite 
for a species being a vector, although this alone does not 
prove that a species is able to transmit under natural 
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conditions. Hence, where viral RNA is detected in saliva, 
we refer to this as (laboratory) transmission potential 
to differentiate our results from laboratory vector com-
petence demonstrated by transmission to vertebrates, 
and from natural transmission. Additionally, we use the 
term candidate vector to describe mosquito species with 
ecological characteristics such as host-preference and 
habitat type which make them of interest for vector com-
petence evaluation.
Methods
Mosquitoes
Experiments were conducted on adult female mosquitoes 
originating from egg rafts or larvae collected on the Wir-
ral Peninsula, northwest England. Ochlerotatus detritus 
were collected as third- or fourth-instar larvae, or pupae 
from brackish marshland by Little Neston (53°16′37.2″N, 
3°04′06.4″W) between May and October. Culex pipi-
ens egg-rafts were collected from container habitats on 
farmland at University of Liverpool, Leahurst Campus, 
Neston (53°17′25.6″N, 3°01′29.9″W), between May and 
August. Culiseta annulata egg-rafts were collected from 
container habitats (black 15 litre buckets were placed 
to catch rainwater and organic debris, for the purpose 
of attracting ovipositing Cs. annulata) in woodland at 
Ness Botanic Gardens, Little Neston (53°16′11.5″N, 
3°02’48.3″W) between May and August. Individual egg-
rafts were allowed to hatch in covered larval trays. Culi-
seta annulata egg rafts were initially differentiated from 
Cx. pipiens complex rafts based on size, and emerged 
adults were identified morphologically. To separate Cx. 
pipiens from the morphologically identical species Cx. 
torrentium, a small number of larvae hatched from each 
egg raft were identified to species level using restriction 
fragment length polymorphism analysis [37] and lar-
val trays containing larvae identified as Cx. pipiens were 
retained. Immature mosquitoes were reared in a brick-
built, unheated, non-insulated outbuilding (during May 
to November), thereby approximating outdoor shaded 
conditions. Larvae were reared in water collected from 
their larval habitat, supplemented with tap water as nec-
essary. Where supplementary food was required Brewer’s 
Yeast was provided. Adults were allowed to emerge and 
mate in 30 × 30 × 30  cm BugDorms (BugDorm, Tai-
chung, Taiwan). Adults were kept in ambient conditions 
(as for larvae) and were offered 10% sucrose solution on 
cotton wool ad libitum, then transferred to an indoor 
(temperature controlled) insectary on the same day as the 
virus-containing blood meal was offered.
Viruses
Viruses used were the JEV strain CNS138-11 [38], RRV 
(National Collection of Pathogenic Viruses (NCPV) cata-
logue number 0005281v) and VEEV P676 (NCPV cata-
logue number 0605153v). All viruses were cultured and 
titre assayed in Vero cells. Final virus titre in blood meals 
was 1 ×  106 plaque forming units (pfu)/ml for JEV, 5.6 
×  106 50% tissue culture infectious dose  (TCID50)/ml for 
RRV, and 9.5 ×  106 pfu/ml for VEEV. Titres were cho-
sen based on information about viraemia in amplifica-
tion or transport hosts and previously published studies 
investigating laboratory transmission. Titres were limited 
by the stock concentration provided by the respective 
institutions (measured using plaque assay (JEV, VEEV) 
or endpoint dilution assay  TCID50 (RRV)). Virus stocks 
were aliquoted on the day of receipt and stored at -80 °C, 
with aliquots discarded after use to minimise freeze-thaw 
before infection experiments.
Infection
At 10–21 days post-emergence female mosquitoes 
were transferred into 1-litre polypropylene Dispo-
safe containers (The Microbiological Supply Com-
pany, Luton, UK), with a fine mesh covering and were 
starved of sugar for 24 h. They were then allowed to 
feed for up to 3 h, in low light conditions at 21 °C, 
on heparinised human blood (NHS transfusion ser-
vice, Speke, UK) containing the virus. A Hemotek 
membrane feeding apparatus (Discovery Workshops, 
Lancashire, UK) heated to 39  °C was used with the 
membrane provided by the manufacturer. Immediately 
before use this was worn next to human skin for 15–20 
min, to impart human odour, and encourage feeding. 
Blood-fed females were incubated at 18 °C, 21 °C or 24 
°C. Mosquitoes were maintained at this temperature 
for 7–35 days and were provided with 10% sucrose. 
On the day of testing, mosquitoes were immobilised 
with triethylamine (FlyNap, Carolina Biological Sup-
ply Company, Burlington, USA), and their saliva was 
extracted by inserting each mosquito’s proboscis into 
a capillary tube containing mineral oil for 30 min. Each 
mosquito and its expectorate were placed in a separate 
1.5 ml microcentrifuge tube containing 200 µl TRIzol 
reagent (Thermo Fisher Scientific, Waltham, USA), 
kept at room temperature for 2 h to inactivate virus 
and then stored at − 20 °C. Repeat infections were 
carried out for each experimental condition if 30 sur-
viving mosquitoes were not available for testing at all 
time points. In this case another batch of mosquitoes 
was infected, until no further mosquitoes of under 22 
Page 4 of 12Chapman et al. Parasites Vectors          (2020) 13:413 
days post-emergence were available. Our intention was 
to analyse at least 30 surviving mosquitoes for each 
condition. Total numbers infected were not recorded 
due to accidental mortality.
Measuring viral RNA in body and saliva
Semi-quantitative qPCR was used to estimate viral RNA 
quantities in mosquito saliva and bodies. Samples were 
run in duplicate and the mean of these two  Cq values was 
used in further analysis (see Additional file 1: Table S1). 
RNA was extracted using TRIzol reagent as per the man-
ufacturer’s instructions. Samples were stored at − 20 °C 
for up to 14 days before cDNA generation. cDNA was 
generated using Superscript™ Vilo™ (Thermo Fisher 
Scientific). Each 20 µl reaction consisted of 4 µl Super-
script™ Vilo™ MasterMix, 6 µl RNase-free water, and 
10 µl of sample. PCR plates were incubated at 25 °C for 
10 min, then 42 °C for 90 min and the reaction was ter-
minated at 85 °C for 5 min. cDNA was stored at − 20 °C.
TaqMan (Thermo Fisher Scientific) quantitative poly-
merase chain reaction (qPCR) was used to detect the 
presence of viral RNA in the samples. Primer and probe 
sets are shown in Table 1.
TaqMan qPCR assays were performed in a reaction 
volume of 20 µl. The reaction contained 1 × TaqMan 
Gene Expression Master Mix (with ROX passive refer-
ence), TaqMan probe (500 nM for VEEV and RRV assays; 
150 nM for JEV assay), primers (1 µM for VEEV and RRV 
assays; 400 nM for JEV assay) and 2 µl of cDNA or con-
trol substance.
Thermocycler conditions for VEEV and RRV assays 
were: 1 cycle of 95 °C for 10 min, then 45 cycles of 95 °C 
for 15 s, 55 °C for 30 s and 60 °C for 30 s. For the JEV 
assay thermocycler conditions were: 1 cycle of 95 °C for 
10 min, then 45 cycles of 95 °C for 15 s, and 60 °C for 1 
min. Amplification and detection were performed using 
an Agilent Mx3005P qPCR System (Agilent Technolo-
gies, Santa Clara, USA).
Analysis
For each cDNA generation, a no-template control 
(nuclease-free water), and a positive control (viral RNA) 
were assayed. For each TaqMan assay, a positive control 
(cDNA generated from neat virus RNA) and negative 
controls (nuclease-free water, and cDNA generated from 
a mosquito infected with JEV for VEEV and RRV assays 
or infected with VEEV for JEV assays) were included.
For each virus, a standard curve for the PCR was gen-
erated using 3 replicates of 10-fold serial dilutions with 
a dynamic range of 7 logs using the stock virus in order 
to allow calculation of estimated PCR efficiency (see 
Additional file 2: Text S1): JEV – 103.19%, RRV – 95.04%, 
VEEV – 91.66%.
The copy number of viral RNA in the stock virus was 
not known and therefore viral copy number cannot be 
estimated from  Cq value. Samples were considered posi-
tive for viral RNA if the  Cq value obtained from the sam-
ple was ≤ 40.
To aid the interpretation of  Cq values on plots, an ‘esti-
mated relative RNA quantity’ is represented for each 
viral RNA, on a scale showing orders of magnitude, rela-
tive to a sample producing a  Cq value of 40. The method 
used here is semi-quantitative and the scales presented 
on plots correspond to transformed  Cq values and not 
to absolute quantification of virus or RNA quantity (see 
Additional file 2: Text S1).
In this study, for percentage of mosquitoes with detect-
able viral RNA in bodies of saliva the denominator was 
the total number of mosquitoes successfully feeding on 
infected blood and surviving until the point of sampling.
All statistical analyses were performed using the sta-
tistical programming language R [39]. The difference 
in two proportions was analysed using Fisher’s exact 
test (fisher.test); the Shapiro-Wilks test was used to test 
whether data were normally distributed (shapiro.test). 
The Kruskal-Wallis rank sum test (kruskal.test) was used 
to test for significant differences in  Cq values between 
groups, and pairwise Mann Whitney-U tests (wilcox.test) 
with a Holm correction [40], were used to test for signifi-
cant differences between each pair of groups.
Results
Detection of JEV RNA in Cs. annulata
Culiseta  annulata was evaluated at 3 time points after 
challenge by ingestion with JEV and incubation at 21 °C 
and 24 °C (Table 2). The trend in percentage of mosqui-
toes with viral RNA in bodies and saliva was a reduction 
Table 1 Primer and probe sets for the TaqMan assays
a Designed using Primer-BLAST [82]
Virus Sense primer (5’-3’) Probe (5’-3’) Antisense primer (5’-3’) Reference
VEEV TCC ATG CTA ATG CYA GAG CGT TTT CGCA Fam-TGA TCG ARA CGG AGG TRG AMCCA TCC 
-Tamra
TGG CGC ACT TCC AAT GTC HAGGAT Vina-Rodriqez et al. [45]
RRV TTG CCG GTG GGT AGA GAG AA Fam-ACC ACA CTT TGG CGT AGA GC-Tamra TCT GGC GGT GTA TGC ATG TC This  studya
JEV ATC TGG TGY GGY AGT CTC A Fam-CGG AAC GCG AWC CAG GGC AA-Tamra CGC GTA GAT GTT CTC AGC CC Pyke et al. [81]
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over time and both parameters are reduced at 24 °C com-
pared to 21 °C. The range of estimated relative JEV RNA 
quantity for mosquito bodies and saliva is presented in 
Fig. 1.
Detection of JEV RNA in Cx. pipiens
A small number of Cx.  pipiens were tested at one tem-
perature (18 °C) and one time point (21 days). All 18 
mosquitoes tested positive for viral RNA in bodies, and 
13 (72.2%) had viral RNA in saliva. Median  Cq values pro-
duced from mosquito bodies and saliva were 33.85 and 
36.78 respectively.
Detection of RRV RNA in Oc. detritus
Ochlerotatus detritus exposed to a blood meal containing 
RRV were evaluated at 5 time points after challenge, and 
incubation at 21 °C and 24 °C (Table 3). The percentage 
of mosquitoes expectorating viral RNA was highest after 
7 days with an incubation temperature of 24 °C.
At both temperatures, by 21 days, the percentage of 
mosquitoes expectorating RRV RNA and the proportion 
with detectable viral RNA in their bodies had dropped 
significantly compared to those at 7 days (P < 0.001 in 
both cases). This observation correlates with the drop in 
estimated quantity of RNA detected in these bodies seen 
at 21 °C (Fig. 2).
Cq values were not normally distributed (Shapiro-Wilks 
test) and variances were significantly different between 
groups. There were significant differences between 
incubation periods in the  Cq values of mosquito bod-
ies maintained at 21 °C (χ2 =13.67, df = 3, P = 0.003). 
Pairwise tests indicated a significant difference in  Cq val-
ues between mosquito bodies after a 14 day incubation 
period, compared to a 7 day incubation period at 21 °C (P 
= 0.012).
Detection of VEEV RNA in Oc. detritus
Ochlerotatus.  detritus was evaluated at 4 time points 
after challenge by ingestion with VEEV and incubation at 
18 °C, 21 °C and 24 °C (Table  4; only 3 time points for 
18 C). In general, the trend over time is for increased 
proportions of mosquitoes with VEEV RNA detected in 
the body and higher estimated relative RNA quantities 
in bodies (Fig. 3), but few mosquitoes expectorated viral 
RNA.
Discussion
Here we present the first demonstration of laboratory 
transmission potential of any European mosquito popu-
lation for VEEV and RRV, with RNA of both viruses 
detected in Oc. detritus saliva. Ochlerotatus detritus has 
previously been shown to be able to produce flaviviruses 
in saliva [32]; to our knowledge, this is the first study 
demonstrating it can produce viral RNA of an alphavirus 
(RRV). Detection of VEEV RNA in the saliva of Oc. detri-
tus was infrequent, despite high proportions of mosquito 
bodies being infected, marking this species as a potential 
but inefficient laboratory transmitter.
We found that over 70% of Cx. pipiens produced RNA 
of JEV in saliva after being maintained at 18 °C, similar 
to the mean temperature of some recent UK summer 
months. Culex pipiens has previously been shown to be 
capable of laboratory transmission of JEV after 11 days 
when maintained at 27 °C [28]. Lower incubation temper-
atures had not been previously used for this mosquito-
virus pair. Further work in order to confirm laboratory 
competence and estimate the lower temperature limit for 
replication of JEV in Cx. pipiens is warranted as Cx. pipi-
ens is a widespread vector of West Nile virus [41–43] and 
has been considered a potential vector of JEV in Europe 
[28].
We add Cs. annulata to the number of European spe-
cies shown to produce JEV RNA in saliva. To our knowl-
edge, Cs. annulata has only been tested once before for 
vector competence for an arbovirus [44]: it was shown to 
be competent but was not an efficient vector of Tahnya 
virus (Bunyaviridae; Orthobunyavirus).
The results of this study for RRV and Oc. detritus, and 
for JEV and Cs. annulata, differ from the familiar pattern 
of number of mosquitoes positive for viral RNA increas-
ing over time and with temperature: (i) in some instances, 
a decrease in viral RNA titre at later time points; and (ii) a 
decrease in viral RNA titre with higher maintenance tem-
perature. It seems plausible that for these non-naturally 
Table 2 Summary of JEV RNA detection in saliva and bodies of Cs. annulata 
Temperature (°C) Timepoint 
(days)
Total no. of surviving 
mosquitoes
No. with detectable 
viral RNA in body
No. with detectable 
viral RNA in saliva
% with detectable 
viral RNA in body
% with detectable 
viral RNA in saliva
21 14 30 13 9 43.3 30.0
21 35 20 15 57.1 20.0
28 30 3 1 10.0 3.3
24 14 30 6 0 20.0 0
21 24 4 0 16.7 0
28 5 0 0 0 0
Page 6 of 12Chapman et al. Parasites Vectors          (2020) 13:413 
occurring mosquito-virus interactions we are able to 
generate infections that are unstable over time; with the 
virus killing the mosquito or the mosquito clearing the 
virus, both processes facilitated by higher temperatures 
or longer incubation. Unfortunately, survival rates in 
infected or non-infected mosquitoes was not investigated 
in this study. Thus, we are unable to ascertain whether 
viral infection was causing mosquito mortality, which 
could account for the detection of more uninfected mos-
quitoes at later time points.
An important question in mosquito infection studies is 
whether the titre of virus in the blood meal reflects the 
virus titre in natural hosts. If the experimental titres are 
much higher than occur naturally, demonstrating infec-
tivity to the mosquitoes may not indicate true transmis-
sion potential. Estimated blood-meal virus titres of RRV 
(5.6 ×  106  TCID50/ml) and VEEV (9.5 ×  106 pfu/ml) used 
in this study were generally comparable to host virae-
mias. Reported titres of RRV include 1 ×  105.5  TCID50/
ml in humans [45] and 1 ×  106.3 50% suckling mouse 
intracerebral lethal dose  (SMICLD50)/ml in horses [46]. 
Reported titres of VEEV in horses range from 1 ×  105.3 
to 1 ×  108.5  SMICLD50/ml [47–49]. The estimated blood-
meal titre of JEV used here (1 ×  106 pfu/ml) exceeds that 
reported for natural hosts by one to two logs, such as 
pigs (1 ×  104.5 TCID50/ml [50] or 1 ×  104  SMICLD50/ml 
[51, 52]), ardeid birds (1 ×  104.3  SMICLD50 /ml [53]) and 
non-ardeid birds (1 ×  105.4 pfu/ml [54]). In the present 
study, titres in blood meals were estimated from frozen 
stock solution maximum titres. A previous study by our 
group using the same method of titre estimation for JEV 
with similar storage conditions, overestimated the titre 
in blood meals by 2 logs [55]; therefore it was considered 
likely that the final titre in blood meals used in this study 
would be, in reality, closer to 1 ×104 pfu/ml than 1 ×  106 
pfu/ml and therefore, would approximate the JEV titre in 
natural hosts.
Confirmation that a mosquito species is a labora-
tory competent vector ideally involves demonstration of 
transmission from one vertebrate host to another. The 
use of vertebrate hosts in vector competence experi-
ments has diminished in recent years, due to animal 
Fig. 1 Box-and-whiskers plots for range of estimated relative 
quantities of JEV RNA in samples from Cs. annulata. Boxes indicate 
2nd and 3rd quartiles, vertical lines upper and lower quartiles, and 
horizontal lines the median. Black points indicate outliers. Red points 
indicate mean values
Table 3 Summary of RRV RNA detection in saliva and bodies of Oc. detritus 
Temperature (°C) Timepoint 
(days)
Total no. of surviving 
mosquitoes
No. with detectable 
viral RNA in body
No. with detectable 
viral RNA in saliva
% with detectable 
viral RNA in body
% with detectable 
viral RNA in saliva
21 7 33 23 9 69.7 27.3
14 30 25 11 83.3 36.7
21 30 2 0 6.7 0
28 20 1 0 5.0 0
35 10 0 0 0 0
24 7 22 16 11 72.7 50.0
14 30 4 0 13.3 0
21 30 0 0 0 0
28 12 0 0 0 0
35 15 0 0 0 0
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welfare considerations, and therefore alternative methods 
have been developed as a proxy for natural transmission 
[56–59]. These include mosquito infection by artificial 
blood meal with a comparable viral titre to viraemias 
seen in vertebrate hosts, and transmission estimated by 
saliva extraction through forced salivation. Quantifica-
tion of infectious virus in the expectorate of mosquitoes 
can be achieved using cell culture, however this is techni-
cally challenging [60] and was not possible in this study. 
The present study uses detection of viral RNA in saliva, 
thus the results should be interpreted with caution: while 
detection of viral RNA in saliva is an important finding 
[32, 60, 61], we have not yet demonstrated the produc-
tion of infectious virus.
For demonstration of the potential of a mosquito spe-
cies to become an ecologically significant vector in the 
event of virus introduction, other factors affecting vec-
torial capacity need to be evaluated [62]: these factors 
include the presence of suitable hosts, mosquito longev-
ity and biting rates and the impact of environmental tem-
peratures. All three viruses have complex enzootic cycles 
involving more than one vertebrate host and more than 
one mosquito vector. Importantly, epizootic outbreaks of 
VEEV and RRV may occur involving equines or humans 
as the major vertebrate hosts. Humans are considered 
potential transport hosts for RRV [22] and rarely, VEEV 
[63]. By contrast, humans and equines are considered 
to be dead-end host of JEV, not able to produce a high 
enough viraemia to infect mosquitoes. Pigs are consid-
ered amplification hosts for JEV and experimental pig-pig 
transmission has been observed [50]. Therefore, it is at 
least theoretically possible for a mammal-biting mosquito 
such as Oc. detritus to be a vector of all three viruses in an 
epizootic outbreak.
The risk of transmission of equine arboviruses in the 
UK, including consideration of the potential for virus 
introduction or emergence [1, 13, 64] as well as the ecol-
ogy of British mosquito species which may be consid-
ered candidate vectors, is discussed elsewhere [65]. Here, 
we focus on the mosquito species used in this study in 
Fig. 2 Box-and-whiskers plots for range of estimated relative RRV 
RNA quantity in samples from Oc. detritus. Boxes indicate 2nd and 3rd 
quartiles, vertical lines upper and lower quartiles, and horizontal lines 
the median. Black points indicate outliers. Red points indicate mean 
values
Table 4 Summary of VEEV RNA detection in saliva and bodies of Oc. detritus 
Temperature (°C) Timepoint 
(days)
Total no. of surviving 
mosquitoes
No. with detectable 
viral RNA in body
No. with detectable 
viral RNA in saliva
% with detectable 
viral RNA in body
% with detectable 
viral RNA in saliva
18 14 25 3 0 12 0
21 28 23 9 82.1 32.1
28 30 23 2 76.7 6.7
21 7 29 11 0 37.9 0
14 30 23 3 76.7 10.0
21 28 25 1 89.3 3.6
28 15 5 0 33.3 0
24 7 30 22 7 73.3 23.3
14 28 25 0 89.3 0
21 27 27 6 100.0 22.2
28 30 27 1 90.0 3.3
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relation to the ecological attributes which make them 
of interest as candidate vectors for the viruses tested. 
Ochlerotatus detritus is considered the primary species 
associated with brackish water that causes biting nui-
sance for humans in the UK [66, 67] and was trapped on 
seven of nine saltmarsh associated equine premises in the 
UK in a recent study [68]. Natural exposure of horses to 
Oc. detritus on the Wirral Peninsula, UK, has been used 
for testing of mosquito repellents, confirming regular 
blood-feeding from horses [65]. Culiseta annulata can be 
a locally significant nuisance species, noted particularly 
in early spring and late autumn in the UK, breeds in a 
variety of natural and artificial habitats, both shaded and 
unshaded and is widespread [66, 69]. Culiseta annulata 
has been shown to bite horses and other large animals in 
the UK [65, 68, 70] and engorged females have also been 
captured in horse baited traps in France and Switzerland 
[61, 71]. This species was found on 75% (24/32) equine 
premises sampled in a previous study in the UK [68]. 
Biting nuisance was experienced on two such premises 
during sampling, which was strongly suspected to be 
related to poorly drained muck-heaps which contained 
high densities of larvae identified as Cs.  annulata/alas-
kaensis/subochrea and this species is associated with 
manure and water with a high nitrogen content [69, 72]. 
Culiseta annulata takes blood meals from birds as well 
as mammals including swine (an amplification host for 
JEV), both in the UK and elsewhere [73, 74] and has been 
considered a potential bridge-vector for WNV [75, 76]. 
Culex pipiens are considered abundant and widespread 
in the UK [75] and were found on 65% (15/23) of equine 
premises where suitable water sources were found in a 
previous study [68]. On all but four of these sites, mam-
mal biting (candidate bridge-vector) species such as Cs. 
Fig. 3 Box-and-whiskers plots for range of estimated relative values of VEEV RNA in samples from Oc. detritus. Boxes indicate 2nd and 3rd quartiles, 
vertical lines upper and lower quartiles, and horizontal lines the median. Black points indicate outliers. Red points indicate mean values
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annulata or Oc. detritus were also trapped. In addition, 
Culex pipiens and/or torrentium mosquitoes were iden-
tified in horse-baited traps in the UK during testing for 
efficacy of repellents in a rural location, although these 
were not blood-fed [65]. In the UK, Culex pipiens eco-
forms pipiens and molestus, and hybrids are present. The 
complexity of taxonomy of Cx. pipiens is discussed else-
where [77] and here we use the term Cx. pipiens as mos-
quitoes were differentiated from Cx. torrentium but no 
attempt was made to define which ecoform they repre-
sented. For JEV, bird-mosquito-bird and bird-mosquito-
mammal (bridge vector) transmission are likely to be 
required for ongoing transmission in the event of virus 
emergence, therefore vector competence studies of UK 
populations of ornithophilic species such as Cx. pipiens 
would provide important information. Overall, due to 
their widespread distribution and relative abundance, Cx. 
pipiens, whether ornithophilic or more catholic in their 
feeding preferences, must be considered a candidate vec-
tor (enzootic or as a bridge-vector) for JEV and here we 
demonstrate its ability to produce viral RNA in saliva at 
lower temperatures than previously shown.
Considering the current UK climate, the risk of enzo-
otic establishment of these viruses appears low, however 
if climate change substantially alters factors such as the 
distribution, density and vectorial capacity of potential 
mosquito vectors then the risk of epizootic transmission 
may increase. The lowest maintenance temperature used 
in this study was 18 °C at which temperature, Cx. pipiens 
was able to produce JEV RNA in saliva. Assessment of 
vector potential at lower temperatures would be required 
in order to inform risk assessment for current UK climate 
conditions, although it is important to note that since the 
year 2000 there have been 10 years where July or August, 
or both, have had a mean temperature > 18 °C in East 
Anglia and 8 years for south east and the central south 
of England [78]. The 2.2 km convection permitting model 
(part of UKCP18) using the high emission scenario 
(RCP8.5) suggests that UK summer temperatures will 
rise by 3.6–5 °C for 2061–2080 [79] therefore assessment, 
at 21 °C was considered relevant to predicted future cli-
mate conditions. We detected viral RNA in saliva in mos-
quitoes incubated at 21 °C for all three virus-mosquito 
combinations.
As discussed previously, investigation of mosquito spe-
cies’ potential for laboratory transmission of arboviruses 
by detection of viral RNA in saliva must be treated with 
a degree of caution and evaluation of vector competence 
and (even more so) estimation of potential vectorial 
capacity require additional information. Limitations of 
the present study include the relatively low numbers of 
Cx. pipiens used, lack of survival data and limited range 
of temperatures and time-points.
Further work which would be useful in evaluating the 
ability of UK populations of these mosquito species to 
transmit RRV, JEV or VEEV would include (but is not 
limited to): confirmation of production of infectious 
virus in saliva using cell titration methods; investigation 
of lower temperatures and shorter incubation times than 
those used in this study; and investigation of the appar-
ent instability of mosquito infections, including at lower 
temperatures than those used in this study, to assess 
infection dynamics at temperatures to which these popu-
lations are adapted.
Conclusions
The present study demonstrated that mosquito popula-
tions present in the UK are able to produce viral RNA 
in saliva after feeding on blood containing arboviruses 
which affect people and equines, and which are asso-
ciated with significant morbidity and / or mortality in 
both groups. For all mosquito-virus pairs viral RNA was 
produced in the saliva of some mosquitoes. Ochlerota-
tus  detritus demonstrated the ability to produce RRV 
RNA in saliva and low numbers produced VEEV RNA in 
saliva. Culiseta annulata and Cx.  pipiens produced JEV 
RNA in saliva. For some mosquito-virus pairs there was 
evidence that infections were unstable and viral RNA 
decreased over time. Further work on the lower tempera-
ture limit for replication of JEV in Cx. pipiens, and confir-
mation that the RNA in saliva is indicative of infectious 
virus is warranted.
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